Effects of advanced glycation end products on cytosolic Ca2+ signaling of cultured human mesangial cells

Journal of the American Society of Nephrology

Volumn 10, Issue 7, 1999, Pages 1478-1486

  Menè, Paolo ^a   Pascale, Carmen ^b   Teti, Anna ^b   Bernardini, Silvia ^b   Cinotti, Giulio A ^b   Pugliese, Francesco ^b  

^a POLICLINICO UMBERTO I   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; ANGIOTENSIN; BOVINE SERUM ALBUMIN; CALCIUM ION; GLUCOSE 6 PHOSPHATE; PROTEIN KINASE C; VASOCONSTRICTOR AGENT;

ARTICLE; CALCIUM CELL LEVEL; CAPILLARY PRESSURE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; HUMAN; HUMAN CELL; IN VITRO STUDY; MESANGIUM CELL; MICROFLUOROMETRY; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; ULTRAFILTRATION;

EID: 0033034122     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Grandhee SK, Monnier VM: Mechanism of formation of the Maillard protein cross-link pentosidine. J Biol Chem 266: 11654-11660, 1991
2. Monnier VM, Nagaraj RH, Portero-Otin M, Glomb M, Elgawish A-H, Sell DR, Friedlander MA: Structure of advanced Maillard reaction products and their pathological role. Nephrol Dial Transplant 11[Suppl 5]: 20-26, 1996
3. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321, 1988
4. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, Friedman EA, Cerami A, Vlassara H: Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325: 836-842, 1991
5. Schmidt AM, Hori O, Cao R, Van SD, Brett J, Wautier JL, Ogawa S, Kuwabara K, Matsumoto M, Stern D: RAGE: A novel cellular receptor for advanced glycation end products. Diabetes 45[Suppl 3]: S77-S80, 1996
6. El Khoury J, Thomas C, Loike J, Hickman S, Cao L, Silverstein SC: Macrophages adhere to glucose-modified basement membrane collagen IV via their scavenger receptors. J Biol Chem 269: 10197-10200, 1994
7. Makino H, Shikata K, Hironaka K, Kushiro M, Yamasaki Y, Sugimoto H, Ota Z, Araki N, Horiuchi S: Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy. Kidney Int 48: 517-526, 1995
8. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ: Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci USA 89: 2873-2877, 1992
9. Williams B: Glucose-induced vascular smooth muscle dysfunction: The role of protein kinase C. J Hypertens 13: 477-486, 1995
10. Guzman NJ, Kurian P, Andaloro VJ, Tisher CC, Crews FT: Effects of glucose on receptor-mediated phosphoinositide hydrolysis and second messenger generation in rat glomerular mesangial cells. J Am Soc Nephrol 2: 179-190, 1991
11. Menè P, Pugliese G, Pricci F, Di Mario U, Cinotti GA, Pugliese F: High glucose inhibits cytosolic calcium signaling in cultured rat mesangial cells. Kidney Int 43: 585-591, 1993
12. Craven PA, Caines MA, DeRubertis FR: Sequential alterations in glomerular prostaglandin and thromboxane synthesis in diabetic rats: Relationship to the hyperfiltration of early diabetes. Metabolism 36: 95-103, 1987
13. 2+ influx in cultured rat mesangial cells by a protein kinase C-dependent mechanism. Diabetologia, 40: 521-527, 1997
14. Bank N: Mechanisms of diabetic hyperfiltration. Kidney Int 40: 792-807, 1991
15. Schwieger J, Fine LG: Renal hypertrophy, growth factors, and nephropathy in diabetes mellitus. Semin Nephrol 10: 242-253, 1990
16. Steffes MW, Østerby R, Chavers B, Mauer SM: Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38: 1077-1081, 1989
17. Williams B, Schrier RW: Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells. J Clin Invest 92: 2889-2896, 1993
18. Williams B, Schrier RW: Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes 41: 1464-1472, 1992
19. Craven PA, DeRubertis FR: Protein kinase C is activated in glomeruli from streptozotocin diabetic rats: Possible mediation of glucose. J Clin Invest 83: 1667-1675, 1989
20. Haller H, Baur E, Quass P, Behrend M, Lindschau C, Distler A, Luft FC: High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells. Kidney Int 47: 1057-1067, 1995
21. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell S-E, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL: Amelioration of vascular dysfunctions in diabetic rats by an oral PKCβ inhibitor. Science 272: 728-731, 1996
22. 2 in cultured mesangial cells. Am J Physiol 255: F1059-F1069, 1988
23. 2+ exchanger in cultured human mesangial cells. Kidney Int 38: 1199-1205, 1990
24. Menè P, Teti A, Pugliese F, Cinotti GA: Calcium-release-activated calcium influx in cultured human mesangial cells. Kidney Int 46: 122-128, 1994
25. Skolnik EY, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara H: Human and rat mesangial cell receptors for glucose-modified proteins: Potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med 174: 931-939, 1991
26. Crowley ST, Brownlee M, Edelstein D, Satriano JA, Mori T, Singhal PC, Schlondorff D: Effects of nonenzymatic glycosylation of mesangial matrix on proliferation of mesangial cells. Diabetes 40: 540-547, 1991
27. Picard S, Parthasarathy S, Fruebis J, Witztum JL: Aminoguanidine inhibits oxidative modification of low density lipoprotein and the subsequent increase in uptake by macrophage scavenger receptor. Proc Natl Acad Sci USA 89: 6876-6880, 1992
28. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985
29. Berridge MJ: Capacitative calcium entry. Biochem J 312: 1-11, 1995
30. Menè P, Pugliese F, Cinotti GA: Regulation of capacitative calcium influx in cultured human mesangial cells: Roles of protein kinase C and calmodulin. J Am Soc Nephrol 7: 983-990, 1996
31. Menè P: Calcium channel blockers: What they can and what they can't. Nephrol Dial Transplant 12: 25-28, 1997
32. Hoth M, Penner R: Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature 355: 353-356, 1992
33. Putney JW Jr: Capacitative calcium entry revisited. Cell Calcium 11: 611-624, 1990
34. Menè P, Simonson MS, Dunn MJ: Physiology of the mesangial cell. Physiol Rev 69: 1347-1423, 1989
35. Hallam TJ, Jacob R, Merritt JE: Influx of bivalent cations can be independent of receptor stimulation in human endothelial cells. Biochem J 259: 125-129, 1989
36. Ayo SH, Radnik R, Garoni JA, Troyer DA, Kreisberg JI: High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 261: F571-F577, 1991
37. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest 93: 536-542, 1994
38. Ayo SH, Radnik RA, Glass WF, Garoni JA, Rampt E-R, Appling DR, Kreisberg JI: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260: F185-F191, 1991
39. Ziyadeh FN, Han DC, Cohen JA, Guo J, Cohen MP: Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: Involvement of the transforming growth factor-β system. Kidney Int 53: 631-638, 1998
40. Nahman NS, Leonhart KL, Cosio FG, Hebert CL: Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells. Kidney Int 41: 396-402, 1992
41. Wolf G, Thaiss F: Hyperglycaemia: Pathophysiological aspects at the cellular level. Nephrol Dial Transplant 10: 1109-1112, 1995
42. Sharma K, Danoff TM, DePiero A, Ziyadeh FN: Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: Possible mediation via protein kinase C. Biochem Biophys Res Commun 207: 80-88, 1995
43. Williams B, Schrier RW: Effect of elevated extracellular glucose concentrations on calcium ion uptake by cultured rat vascular smooth muscle cells. Miner Electrolyte Metab 18: 145-150, 1992
44. Kahn AM, Lichtenberg RA, Allen JC, Seidel CL, Song T: Insulin-stimulated glucose transport inhibits calcium influx and contraction in vascular smooth muscle. Circulation 92: 1597-1603, 1995
45. 2+ influx in rat aortic smooth muscle cells. Am J Physiol 269: C1482-C1488, 1995
46. Kikkawa R, Kitamura E, Fujiwara Y, Arimura T, Haneda M, Shigeta Y: Impaired contractile responsiveness of diabetic glomeruli to angiotensin II: A possible indication of mesangial dysfunction in diabetes mellitus. Biochem Biophys Res Commun 136: 1185-1190, 1986
47. Hurst RD, Whiteside CI, Thompson JC: Diabetic rat glomerular mesangial cells display normal inositol trisphosphate and calcium release. Am J Physiol 263: F649-F655, 1992
48. Williams B, Schrier RW: Effect of elevated extracellular glucose concentration on transmembrane calcium ion fluxes in cultured rat VSMC. Kidney Int 44: 344-351, 1993
49. Seal EE, Eaton DC, Gomez LM, Ma H, Ling BN: Extracellular glucose reduces the responsiveness of mesangial cell ion channels to angiotensin II. Am J Physiol 269: F389-F397, 1995
50. Ling BN, Matsunaga H, Ma H, Eaton DC: Role of growth factors in mesangial cell ion channel regulation. Kidney Int 48: 1158-1166, 1995
51. Levy J, Gavin JR, Sowers JR: Diabetes mellitus: A disease of abnormal cellular calcium metabolism? Am J Med 96: 260-273, 1994
52. Van SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, Stern D: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269: 9889-9897, 1994
53. Neeper M, Schmidt AM, Brett J, Van SD, Wang F, Pan YC, Elliston K, Stern D, Shaw A: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267: 14998-15004, 1992
54. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM: Activation of the receptor for advanced glycation end products triggers a p21(ras) dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272: 17810-17814, 1997
55. Vlassara H, Bucala R, Striker LJ: Pathogenic effects of advanced glycosylation end products: Biochemical, biological and clinical implications for diabetes and aging. Lab Invest 70: 138-152, 1994
56. Striker LJ, Striker GE: Administration of AGEs in vivo induces extracellular matrix gene expression. Nephrol Dial Transplant 11[Suppl 5]: 62-65, 1996
57. Koch KM: Dialysis-related amyloidosis. Kidney Int 41: 1416-1429, 1992